Lake Street Capital Cuts P3 Health Partners (NASDAQ:PIII) Price Target to $4.00

P3 Health Partners (NASDAQ:PIII) had its price objective decreased by Lake Street Capital from $12.50 to $4.00 in a research report released on Friday,Benzinga reports. Lake Street Capital currently has a buy rating on the stock.

Several other research firms also recently commented on PIII. BTIG Research reiterated a “neutral” rating on shares of P3 Health Partners in a research note on Friday, December 12th. Weiss Ratings reissued a “sell (e+)” rating on shares of P3 Health Partners in a research report on Thursday, January 22nd. One equities research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $4.00.

P3 Health Partners Price Performance

PIII opened at $2.94 on Friday. The company has a quick ratio of 0.24, a current ratio of 0.24 and a debt-to-equity ratio of 2.29. The stock has a market cap of $21.20 million, a price-to-earnings ratio of -0.07 and a beta of 0.86. P3 Health Partners has a twelve month low of $1.52 and a twelve month high of $11.30. The company’s 50-day moving average price is $2.46 and its two-hundred day moving average price is $5.14.

P3 Health Partners (NASDAQ:PIII) last released its earnings results on Thursday, March 26th. The company reported ($23.02) earnings per share for the quarter, missing analysts’ consensus estimates of ($8.06) by ($14.96). P3 Health Partners had a negative net margin of 10.14% and a negative return on equity of 302.33%. The company had revenue of $384.81 million for the quarter, compared to the consensus estimate of $357.65 million. As a group, equities analysts expect that P3 Health Partners will post -0.67 earnings per share for the current year.

Institutional Trading of P3 Health Partners

An institutional investor recently raised its position in P3 Health Partners stock. Trinity Financial Advisors LLC lifted its holdings in shares of P3 Health Partners Inc. (NASDAQ:PIII) by 4.6% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 26,678 shares of the company’s stock after buying an additional 1,178 shares during the quarter. Trinity Financial Advisors LLC owned about 0.37% of P3 Health Partners worth $239,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 7.75% of the company’s stock.

About P3 Health Partners

P3 Health Partners is a healthcare technology and services company that delivers data-driven solutions to support health plans in improving quality measures, risk adjustment accuracy and operational efficiency. The company’s platform integrates advanced analytics, reporting capabilities and workflow automation to help clients optimize performance across value-based care programs and regulatory requirements.

The company’s core offerings include quality measurement and reporting for HEDIS, STAR and other performance frameworks, risk adjustment coding and audit services, and population health analytics.